<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02459535</url>
  </required_header>
  <id_info>
    <org_study_id>ILIAS-1</org_study_id>
    <nct_id>NCT02459535</nct_id>
  </id_info>
  <brief_title>Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1</brief_title>
  <acronym>ILIAS-1</acronym>
  <official_title>Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Institute of Human Nutrition</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Institute of Human Nutrition</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft
      drinks may play a role in the development of diabetes.

      Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence
      metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and
      even modulate incretin release.

      However, it is unclear, if these findings are valid for all kinds of AS, as they are
      chemically different. Furthermore, data on human subjects are sparse and controversial.

      The investigators will therefore conduct 7 consecutive single oral stimulations with glucose
      or AS alone or a combination. Three different AS will be tested.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological data suggest, that not only sugar-based, but also artificially sweetened soft
      drinks may play a role in the development of diabetes.

      Recent studies in animals and humans have shown, that artificial sweeteners (AS) influence
      metabolic responses after glucose ingestion, possibly alter the intestinal microbiome and
      even modulate incretin release.

      However, it is unclear, if these findings are valid for all kinds of AS, as they are
      chemically different. Up to now, no single study has ever compared metabolic responses to
      different AS in the same subjects. Furthermore, data on human subjects are sparse and
      controversial. This is partially explained by different methodical approaches such as
      intragastral/intraduodenal application of AS, rather than conventional oral consumption.

      The investigators will therefore conduct 7 consecutive single oral stimulations with glucose
      or AS alone or a combination. Three different AS will be tested: saccharin, aspartame and
      sucralose.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in GIP release</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in GLP-1 release</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in GLP-2 release</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in PYY release</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in insulin release</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in combined blood levels of glucose and insulin, expressed in calculated indices for insulin secretion</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in combined blood levels of glucose and insulin, expressed in calculated indices for insulin sensitivity</measure>
    <time_frame>120 mins</time_frame>
    <description>comparison between all seven interventions</description>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Pre-diabetes</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Glucose only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 54 g Glucose in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose + Saccharin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 54 g Glucose + 0,112 g Saccharin in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saccharin only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 0,112 g Saccharin in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose + Aspartame</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 54 g Glucose 0,197 g Aspartame in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aspartame only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 0,197 g Aspartame in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose + Sucralose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 54 g Glucose + 0,088 g Sucralose in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sucralose only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>oral ingestion of 0,088 g Sucralose in 300 ml water at t=0 in fasted state; blood samples over 120 mins</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oral stimulation glucose</intervention_name>
    <description>oral stimulation with glucose, AS or glucose+AS in fasted state, blood samples from fasted state up to 120 min post-ingestion</description>
    <arm_group_label>Glucose only</arm_group_label>
    <arm_group_label>Glucose + Saccharin</arm_group_label>
    <arm_group_label>Glucose + Aspartame</arm_group_label>
    <arm_group_label>Glucose + Sucralose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oral stimulation saccharin</intervention_name>
    <arm_group_label>Glucose + Saccharin</arm_group_label>
    <arm_group_label>Saccharin only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oral stimulation aspartame</intervention_name>
    <arm_group_label>Glucose + Aspartame</arm_group_label>
    <arm_group_label>Aspartame only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oral stimulation sucralose</intervention_name>
    <arm_group_label>Glucose + Sucralose</arm_group_label>
    <arm_group_label>Sucralose only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy

        Exclusion Criteria:

          -  metabolic disorders such as diabetes, hypothyroidism, corticoid therapy, heart or lung
             disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan Kabisch, Dr. med.</last_name>
    <phone>030 450 514</phone>
    <phone_ext>429</phone_ext>
    <email>stefan.kabisch@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andreas F.H. Pfeiffer, Prof. Dr. med.</last_name>
    <phone>033200 88 2771</phone>
    <email>afhp@dife.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>German Institut for Human Nutrition; Department for Clinical Nutrition</name>
      <address>
        <city>Nuthetal</city>
        <state>Brandenburg</state>
        <zip>14458</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <phone>033200 88 2775</phone>
      <email>margrit.kemper@dife.de</email>
    </contact>
    <investigator>
      <last_name>Margrit Kemper, Dr. med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2015</study_first_submitted>
  <study_first_submitted_qc>June 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2015</study_first_posted>
  <last_update_submitted>November 21, 2016</last_update_submitted>
  <last_update_submitted_qc>November 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>German Institute of Human Nutrition</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Andreas F. H. Pfeiffer</investigator_full_name>
    <investigator_title>Director, Department of Clinical Nutrition</investigator_title>
  </responsible_party>
  <keyword>incretin release</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Incretins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

